The first generic versions of Celebrex capsules have been approved by the US Food and Drug Administration (FDA). Celebrex is a treatment for rheumatoid arthritis, osteoarthritis, acute pain, and other conditions. Celecoxib is the generic name.
“It is important for patients to have access to affordable treatment options for chronic conditions,” said Janet Woodcock, M.D., director of the FDA’s Center for Drug Evaluation and Research.
More than 60% of those who use Celebrex are over 60 years of age, according to CVS Pharmacies. More women are prescribed the medication than men.
Generic prescription drugs approved by the FDA have the same high quality and strength as brand-name drugs. Their manufacturing and packaging sites must pass the same quality standards as those of brand-name drugs.
Teva Pharmaceutical Industries received approval to market celecoxib capsules in 50 milligram, 100 mg, 200 mg, and 400 mg strengths, and has 180-day exclusivity on the 100 mg, 200 mg, and 400 mg strength products. Last month, according to Business Wire, Teva entered an agreement with Pfizer related to Teva’s generic version of Celebrex® (celecoxib) 50, 100, 200 and 400 mg capsules in the US.
Teva may begin to market the generic version in December. The US, according to Drugs.com, is one of two countries that permit companies to advertise in a direct-to-consumer manner.